These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15561451)

  • 1. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
    Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M
    Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact exerted by the severity of recreational drug abuse on the different components of the executive function].
    Verdejo A; Orozco-Giménez C; Meersmans Sánchez-Jofré M; Aguilar de Arcos F; Pérez-García M
    Rev Neurol; 2004 Jun 16-30; 38(12):1109-16. PubMed ID: 15229821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
    Fernández-Serrano MJ; Lozano O; Pérez-García M; Verdejo-García A
    Drug Alcohol Depend; 2010 Jun; 109(1-3):57-64. PubMed ID: 20064697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
    Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
    Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities.
    Fernández-Serrano MJ; Pérez-García M; Perales JC; Verdejo-García A
    Eur J Pharmacol; 2010 Jan; 626(1):104-12. PubMed ID: 19836375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal working memory deficits in current and previous users of MDMA.
    Wareing M; Fisk JE; Murphy P; Montgomery C
    Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT; Bechara A; Rizzo M; Ramaekers JG
    J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
    Dafters RI
    Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
    Piechatzek M; Indlekofer F; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    Hum Psychopharmacol; 2009 Dec; 24(8):650-65. PubMed ID: 19946940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.
    Verdejo-García A; Pérez-García M
    Psychopharmacology (Berl); 2007 Mar; 190(4):517-30. PubMed ID: 17136401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of executive impairments on maladaptive explanatory styles in substance abusers: clinical implications.
    García AV; Torrecillas FL; de Arcos FA; García MP
    Arch Clin Neuropsychol; 2005 Jan; 20(1):67-80. PubMed ID: 15620814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
    Lundqvist T
    Pharmacol Biochem Behav; 2005 Jun; 81(2):319-30. PubMed ID: 15925403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.